Page last updated: 2024-09-03

s 20928 and Adenocarcinoma

s 20928 has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, AR; Dai, J; Dubocovich, ML; Hill, SM; Yuan, L1

Other Studies

1 other study(ies) available for s 20928 and Adenocarcinoma

ArticleYear
MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
    Molecular and cellular endocrinology, 2002, Jun-28, Volume: 192, Issue:1-2

    Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Intercellular Signaling Peptides and Proteins; Melatonin; Mucins; Muscle Proteins; Naphthalenes; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neuropeptides; Peptides; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Melatonin; Recombinant Fusion Proteins; RNA, Messenger; RNA, Neoplasm; Transfection; Trefoil Factor-2; Trefoil Factor-3; Tumor Cells, Cultured

2002